Chronic lung allograft dysfunction

Disease

1 paper1 finding

  • Humans1

Interventions

1

SGLT2 inhibitors

no changein humans1

1 study
  1. SGLT2 inhibitors have no effect on chronic lung allograft dysfunction in humans.

    “Among the small number of exposed patients, no clear excess in early complications, CLAD, or death was observed.”

    Humansprimary isolated lung transplantn = 443

    Early safety observations of peri-transplant SGLT2 inhibitor use in lung transplant recipients

    Journal of thoracic disease26 Jun 2026

More on SGLT2 inhibitors

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months